Dynamic Technology Lab Private LTD Adverum Biotechnologies, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $31,971 - $55,335	-15,371 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.36 - $10.56 $51,646 - $162,317	15,371 New	15,371 $54,000
Q1 2021 May 14, 2021	SELL	$9.26 - $14.36 $249,918 - $387,562	-26,989 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$9.84 - $14.26 $265,571 - $384,863	26,989 New	26,989 $293,000
Q4 2018 Feb 13, 2019	SELL	$2.87 - $5.92 $73,345 - $151,291	-25,556 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $115,002 - $194,225	25,556 New	25,556 $155,000
Q1 2018 May 14, 2018	SELL	$3.65 - $7.95 $37,715 - $82,147	-10,333 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$2.85 - $3.95 $29,449 - $40,815	10,333	10,333 $36,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.